Skip to main content
. 2021 Sep 7;10(2):1497–1509. doi: 10.1007/s40122-021-00302-8

Table 4.

Subgroup analysis of the adverse events between gabapentin and pregabalin groups

Events Incidence (number/total) Heterogeneity Effect model Meta-analysis
Gabapentin Pregabalin I2 (%) P Relative risk (95% CI) P
Sedation 7/24 12/25 Fixed 0.61 [0.29,1.28] 0.19
Dizziness 0/24 1/25 Fixed 0.35 [0.01,8.12] 0.51
Somnolence 6/24 11/25 Fixed 0.57 [0.25,1.29] 0.18
Edema 1/24 1/25 Fixed 1.04 [0.07,15.73] 0.98